| Name | Title | Contact Details |
|---|
At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.
CompManagement Health Systems, Inc. is a Dublin, OH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
PurposeCare is an integrated platform company that coordinates care in the community with a focus on individuals who are dually eligible for Medicaid and Medicare.
We`re making healthcare transformation personal. Driving down the cost of chronic conditions is going to take all of us. Welldoc is here to help with BlueStar, our in-app digital assistant for type 2 diabetes. Chronic with ease. Working together to redefine how engaging and personally transformative technology can be will lead to real change: starting and evolving habits, taking daily responsibility for our well-being, and moving outcomes and costs to a much more manageable place. Technology and teamwork. It`s time to make every moment, every action, every healthcare decision count.
NeuroSigma is a Los Angeles-based life sciences company established to develop TNS technologies with the potential to transform medical practice and patients' lives. NeuroSigma is focused on TNS neuromodulation therapies based on intellectual property licensed on an exclusive basis from the University of California, Los Angeles (UCLA), including TNS therapies for epilepsy, depression, post-traumatic stress disorder (PTSD) and attention-deficit hyperactivity disorder (ADHD).